KUALA LUMPUR: Novo Nordisk, a global healthcare company in diabetes care, will continue to maintain its presence in Malaysia as its regional hub and clinical centre, said chairman Dr Goran Ando.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback